These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 22650352)

  • 41. Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation.
    Rönn F; Kesek M; Karp K; Henein M; Jensen SM
    Europace; 2011 Dec; 13(12):1747-52. PubMed ID: 21712261
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of the effects of AV nodal ablation versus AV nodal modification in patients with congestive heart failure and uncontrolled atrial fibrillation.
    Twidale N; McDonald T; Nave K; Seal A
    Pacing Clin Electrophysiol; 1998 Apr; 21(4 Pt 1):641-51. PubMed ID: 9584293
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High efficiency and workflow of His bundle pacing and atrioventricular node ablation guided by three-dimensional mapping system.
    Sun Y; Yu X; Xiao X; Yin X; Gao L; Zhang R; Dai S; Wang N; Zhang D; Dong Y; Yang Y; Xia Y
    Pacing Clin Electrophysiol; 2020 Oct; 43(10):1165-1172. PubMed ID: 32896924
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of survival for cardiac resynchronization therapy in atrial fibrillation patients with or without atrio-ventricular junction ablation and patients in sinus rhythm: a systematic review and network meta-analysis.
    Xue Y; Wang J; Wang J; Thapa S; Huang K; Peng Y; Qian L; Li J; Ji K
    Heart Fail Rev; 2019 May; 24(3):335-342. PubMed ID: 30610455
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of atrioventricular junction ablation and CRT-D on long-term mortality in patients with left ventricular dysfunction, permanent, refractory atrial fibrillation, and narrow QRS: Results of a propensity-matched analysis.
    Palmisano P; Ziacchi M; Ammendola E; Dell'Era G; Guerra F; Donateo P; Del Giorno G; Laffi M; Coluccia G; Bartoli L; Gaggioli G; Carbone A; Senes J; Dello Russo A; Patti G; Nigro G; Biffi M; Accogli M
    J Cardiovasc Electrophysiol; 2022 Nov; 33(11):2288-2296. PubMed ID: 35930617
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Managing atrial fibrillation in the CRT patient: controversy or consensus?
    Upadhyay GA; Steinberg JS
    Heart Rhythm; 2012 Aug; 9(8 Suppl):S51-9. PubMed ID: 22521931
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biventricular pacing improves cardiac function and prevents further left atrial remodeling in patients with symptomatic atrial fibrillation after atrioventricular node ablation.
    Orlov MV; Gardin JM; Slawsky M; Bess RL; Cohen G; Bailey W; Plumb V; Flathmann H; de Metz K
    Am Heart J; 2010 Feb; 159(2):264-70. PubMed ID: 20152225
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Complete atrioventricular block does not reduce long-term mortality in patients with permanent atrial fibrillation treated with cardiac resynchronization therapy.
    Tolosana JM; Trucco E; Khatib M; Doltra A; Borras R; Castel MÁ; Berruezo A; Arbelo E; Sitges M; Matas M; Guasch E; Brugada J; Mont L
    Eur J Heart Fail; 2013 Dec; 15(12):1412-8. PubMed ID: 23845796
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure.
    Delnoy PP; Ottervanger JP; Luttikhuis HO; Elvan A; Misier AR; Beukema WP; van Hemel NM
    Am J Cardiol; 2007 May; 99(9):1252-7. PubMed ID: 17478153
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Atrioventricular Node Ablation.
    Gasparini M
    Heart Fail Clin; 2017 Jan; 13(1):193-198. PubMed ID: 27886923
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute and long-term outcomes of left-sided atrioventricular node ablation in patients with atrial fibrillation.
    Yorgun H; Canpolat U; Şener YZ; Okşul M; Akkaya F; Ateş AH; Aytemir K
    J Interv Card Electrophysiol; 2020 Dec; 59(3):527-533. PubMed ID: 31853805
    [TBL] [Abstract][Full Text] [Related]  

  • 52. No effects of cardiac resynchronization therapy and right ventricular pacing on the right ventricle in patients with heart failure and atrial fibrillation.
    Majos-Karwacka E; Kraska A; Kowalik I; Smolis-Bak E; Lipiec P; Kasprzak J; Szwed H; Dabrowski R
    Scand Cardiovasc J; 2021 Feb; 55(1):15-21. PubMed ID: 32954833
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy.
    Boriani G; Gasparini M; Landolina M; Lunati M; Proclemer A; Lonardi G; Iacopino S; Rahue W; Biffi M; DiStefano P; Grammatico A; Santini M;
    Eur J Heart Fail; 2011 Aug; 13(8):868-76. PubMed ID: 21558331
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of Atrioventricular Junctional Ablation and Cardiac Resynchronization Therapy in Patients with Chronic Atrial Fibrillation.
    Steinberg JS
    Card Electrophysiol Clin; 2019 Mar; 11(1):147-154. PubMed ID: 30717847
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.
    Röger S; Schneider R; Rudic B; Liebe V; Stach K; Schimpf R; Borggrefe M; Kuschyk J
    Europace; 2014 Aug; 16(8):1205-9. PubMed ID: 24706089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.
    Brignole M; Pentimalli F; Palmisano P; Landolina M; Quartieri F; Occhetta E; Calò L; Mascia G; Mont L; Vernooy K; van Dijk V; Allaart C; Fauchier L; Gasparini M; Parati G; Soranna D; Rienstra M; Van Gelder IC;
    Eur Heart J; 2021 Dec; 42(46):4731-4739. PubMed ID: 34453840
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term effects of cardiac resynchronisation therapy in patients with atrial fibrillation.
    Khadjooi K; Foley PW; Chalil S; Anthony J; Smith RE; Frenneaux MP; Leyva F
    Heart; 2008 Jul; 94(7):879-83. PubMed ID: 18208826
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictive factors of sustained sinus rhythm and recurrent atrial fibrillation after a radiofrequency modified Maze procedure.
    Beukema WP; Sie HT; Misier AR; Delnoy PP; Wellens HJ; Elvan A
    Eur J Cardiothorac Surg; 2008 Oct; 34(4):771-5. PubMed ID: 18768326
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction.
    Machino-Ohtsuka T; Seo Y; Ishizu T; Sugano A; Atsumi A; Yamamoto M; Kawamura R; Machino T; Kuroki K; Yamasaki H; Igarashi M; Sekiguchi Y; Aonuma K
    J Am Coll Cardiol; 2013 Nov; 62(20):1857-65. PubMed ID: 23916940
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The importance of increased percentage of biventricular pacing to improve clinical outcomes in patients receiving cardiac resynchronization therapy.
    Gasparini M; Galimberti P; Ceriotti C
    Curr Opin Cardiol; 2013 Jan; 28(1):50-4. PubMed ID: 23196776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.